Evidence map›Paper›PMID 42680789›Full record

ArticleScientific reports2026

Multivariate synthesis optimization, comprehensive characterization, and surface ligand determination of palladium nanoparticles.

Eduardo Sidinei Chaves, Morgana Lurdes da Rocha, Isabella Tavernaro, Ute Resch-Genger, Björn Meermann

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Eduardo Sidinei ChavesDepartment of Chemistry, Federal University of Santa Catarina, Florianópolis, Brazil. eduardo.chaves@ufsc.br.
Morgana Lurdes da RochaDepartment of Chemistry, Federal University of Santa Catarina, Florianópolis, Brazil.
Isabella TavernaroFederal Institute for Materials Research and Testing, Division 1.2- Biophotonics, Berlin, Germany.
Ute Resch-GengerFederal Institute for Materials Research and Testing, Division 1.2- Biophotonics, Berlin, Germany. ute.resch@bam.de.
Björn MeermannFederal Institute for Materials Research and Testing, Division 1.1- Inorganic Trace Analysis (ITALab), Berlin, Germany. bjoern.meermann@bam.de.ORCID https://orcid.org/0000-0002-8636-0765

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We present a high-throughput approach for synthesizing palladium nanoparticles (PdNPs), which are widely used as catalysts in industrial processes, employing an aqueous reaction medium and a commercial reaction platform that enables parallel reactions under identical conditions. The optimal synthesis conditions, including reaction temperature and the concentrations of Pd, thiol ligands (3-mercaptopropionic acid (MPA) and L-cysteine (Cys)), and reducing agent, were established using a Doehlert experimental design. The purified thiol-capped PdNPs were characterized by transmission electron microscopy (TEM), energy-dispersive X-ray spectroscopy (EDS), dynamic light scattering (DLS), and nanoparticle tracking analysis (NTA), confirming the formation of irregularly shaped PdNP-MPA and PdNP-Cys with polydispersity indices up to 0.270. Single particle-inductively coupled plasma-mass spectrometry (sp-ICP-MS) enabled determination of particle size and size distribution, demonstrating its suitability for characterizing polydisperse nanoparticles with irregular shapes and yielding results consistent with those obtained by TEM and NTA. Bulk ICP-MS was employed to determine the surface density of thiol ligands from the sulfur-to-palladium ratio. Overall, this study demonstrates the potential of multivariate experimental design for PdNP synthesis and the value of complementary analytical techniques for comprehensive nanoparticle characterization.

Indexed as

Broad particle size distributionComplementary NPs characterizationICP-MSLigand densityMetallic nanoparticlesReal-world nanomaterials

Identifiers

PMID42680789
PMCPMC13534612

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.